Skip to content

Kinetics of D-Dimers After Abdominal Surgery

The Kinetics of D-Dimers After Abdominal Surgery as a Function of the Invasiveness of Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00450528
Enrollment
90
Registered
2007-03-22
Start date
2007-02-28
Completion date
2007-10-31
Last updated
2007-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Natural Kicetics of d-Dimers After Surgery

Keywords

D-dimers, surgery, kinetics

Brief summary

The purpose of this study is to investigate the natural kinetics of D-dimers that occur after abdominal surgery.

Detailed description

Venous thromboembolism (VTE) is a potentially fatal disease with an estimated incidence of 0.1%. One third of the VTE occur as pulmonal embolism with a mortality up to 25% (White RH. Circulation 107:2003) Serum d-dimer levels are used as sensitive marker for the diagnosis of VTE (Kelly J et al. Arch Intern Med, 162: 2002). Because of its sensitivity, the determination of serum D-dimer levels is an accepted method to exclude VTE in the outpatient setting meaning that VTE may be excluded in case of normal D-dimer levels (Kelly J. Lancet 359: 2002). The specificity of the D-dimer testing, however, is low. This is true especially in the postoperative phase. The interpretation of elevated D-dimer levels in surgical patients remains elusive. The natural kinetics of D-dimers after surgery is not known. The question to what extent D-dimer levels rise after surgery and how long it may take D-dimer levels to return to normal after surgery is not yet determined. This information is needed to be able to use D-dimer testing for VTE diagnosis in surgical patients. In this study, D-dimer levels are measured in surgical patients immediately before (day 0) and repeatedly after surgery. D-dimer level measurement will be stopped after D-dimer levels returned to normal.

Interventions

None listed

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* patients undergoing elective surgery

Exclusion criteria

* age \< 18 years * patients not speaking german * patients involved in another study * pregnancy * concommitant inflammatory disease * patients with oral anticoagulation * patients having received fresh frozen plasma

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026